Novel drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.

Market Analysis and Insights: Global Pharmaceutics and Novel Drug Delivery Systems Market

In 2019, the global Pharmaceutics and Novel Drug Delivery Systems market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.

Global Pharmaceutics and Novel Drug Delivery Systems Scope and Market Size

Pharmaceutics and Novel Drug Delivery Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutics and Novel Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Pharmaceutics and Novel Drug Delivery Systems market is segmented into Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, Other, etc.

Segment by Application, the Pharmaceutics and Novel Drug Delivery Systems market is segmented into Hospitals & Clinic, Cancer Treatment Centers, Others, etc.

Regional and Country-level Analysis

The Pharmaceutics and Novel Drug Delivery Systems market is analysed and market size information is provided by regions (countries).

The key regions covered in the Pharmaceutics and Novel Drug Delivery Systems market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape and Pharmaceutics and Novel Drug Delivery Systems Market Share Analysis

Pharmaceutics and Novel Drug Delivery Systems market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Pharmaceutics and Novel Drug Delivery Systems business, the date to enter into the Pharmaceutics and Novel Drug Delivery Systems market, Pharmaceutics and Novel Drug Delivery Systems product introduction, recent developments, etc.

The major vendors include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, Bausch&Lomb, Samyang Biopharmaceuticals, Johnson & Johnson, TOLMAR, Astellas, AMAG Pharmaceuticals, AbbVie, Dr Reddy, AstraZeneca, Aspen, Acrotech Biopharma, TWi Pharmaceuticals, etc.

This report focuses on the global Pharmaceutics and Novel Drug Delivery Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutics and Novel Drug Delivery Systems development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Amgen

Teva

Roche

UCB (Union Chimique Belge)

Celgene

Merck

Gilead Sciences

Sanofi

Pfizer

Takeda

Bausch&Lomb

Samyang Biopharmaceuticals

Johnson & Johnson

TOLMAR

Astellas

AMAG Pharmaceuticals

AbbVie

Dr Reddy

AstraZeneca

Aspen

Acrotech Biopharma

TWi Pharmaceuticals

Market segment by Type, the product can be split into

Liposomes

PEGylated Proteins & Polypeptides

Polymer Nanoparticle

Protein–drug Conjugates

Other

Market segment by Application, split into

Hospitals & Clinic

Cancer Treatment Centers

Others

Market segment by Regions/Countries, this report covers

North America

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Pharmaceutics and Novel Drug Delivery Systems status, future forecast, growth opportunity, key market and key players.

To present the Pharmaceutics and Novel Drug Delivery Systems development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Pharmaceutics and Novel Drug Delivery Systems are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Pharmaceutics and Novel Drug Delivery Systems Revenue

1.4 Market Analysis by Type

1.4.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026

1.4.2 Liposomes

1.4.3 PEGylated Proteins & Polypeptides

1.4.4 Polymer Nanoparticle

1.4.5 Protein–drug Conjugates

1.4.6 Other

1.5 Market by Application

1.5.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Application: 2020 VS 2026

1.5.2 Hospitals & Clinic

1.5.3 Cancer Treatment Centers

1.5.4 Others

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends by Regions

2.1 Pharmaceutics and Novel Drug Delivery Systems Market Perspective (2015-2026)

2.2 Pharmaceutics and Novel Drug Delivery Systems Growth Trends by Regions

2.2.1 Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026

2.2.2 Pharmaceutics and Novel Drug Delivery Systems Historic Market Share by Regions (2015-2020)

2.2.3 Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Regions (2021-2026)

2.3 Industry Trends and Growth Strategy

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Challenges

2.3.4 Porter’s Five Forces Analysis

2.3.5 Pharmaceutics and Novel Drug Delivery Systems Market Growth Strategy

2.3.6 Primary Interviews with Key Pharmaceutics and Novel Drug Delivery Systems Players (Opinion Leaders)

3 Competition Landscape by Key Players

3.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Market Size

3.1.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Revenue (2015-2020)

3.1.2 Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Players (2015-2020)

3.1.3 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.2 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio

3.2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)

3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2019

3.3 Pharmaceutics and Novel Drug Delivery Systems Key Players Head office and Area Served

3.4 Key Players Pharmaceutics and Novel Drug Delivery Systems Product Solution and Service

3.5 Date of Enter into Pharmaceutics and Novel Drug Delivery Systems Market

3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

4.1 Global Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Type (2015-2020)

4.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Type (2021-2026)

5 Pharmaceutics and Novel Drug Delivery Systems Breakdown Data by Application (2015-2026)

5.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

5.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Application (2021-2026)

6 North America

6.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)

6.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in North America (2019-2020)

6.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)

6.4 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

7 Europe

7.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)

7.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Europe (2019-2020)

7.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)

7.4 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

8 China

8.1 China Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)

8.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in China (2019-2020)

8.3 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)

8.4 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

9 Japan

9.1 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)

9.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Japan (2019-2020)

9.3 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)

9.4 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

10 Southeast Asia

10.1 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)

10.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Southeast Asia (2019-2020)

10.3 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)

10.4 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

11 India

11.1 India Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)

11.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in India (2019-2020)

11.3 India Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)

11.4 India Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

12 Central & South America

12.1 Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)

12.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Central & South America (2019-2020)

12.3 Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)

12.4 Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

13Key Players Profiles

13.1 Amgen

13.1.1 Amgen Company Details

13.1.2 Amgen Business Overview and Its Total Revenue

13.1.3 Amgen Pharmaceutics and Novel Drug Delivery Systems Introduction

13.1.4 Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020))

13.1.5 Amgen Recent Development

13.2 Teva

13.2.1 Teva Company Details

13.2.2 Teva Business Overview and Its Total Revenue

13.2.3 Teva Pharmaceutics and Novel Drug Delivery Systems Introduction

13.2.4 Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

13.2.5 Teva Recent Development

13.3 Roche

13.3.1 Roche Company Details

13.3.2 Roche Business Overview and Its Total Revenue

13.3.3 Roche Pharmaceutics and Novel Drug Delivery Systems Introduction

13.3.4 Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

13.3.5 Roche Recent Development

13.4 UCB (Union Chimique Belge)

13.4.1 UCB (Union Chimique Belge) Company Details

13.4.2 UCB (Union Chimique Belge) Business Overview and Its Total Revenue

13.4.3 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Introduction

13.4.4 UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

13.4.5 UCB (Union Chimique Belge) Recent Development

13.5 Celgene

13.5.1 Celgene Company Details

13.5.2 Celgene Business Overview and Its Total Revenue

13.5.3 Celgene Pharmaceutics and Novel Drug Delivery Systems Introduction

13.5.4 Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

13.5.5 Celgene Recent Development

13.6 Merck

13.6.1 Merck Company Details

13.6.2 Merck Business Overview and Its Total Revenue

13.6.3 Merck Pharmaceutics and Novel Drug Delivery Systems Introduction

13.6.4 Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

13.6.5 Merck Recent Development

13.7 Gilead Sciences

13.7.1 Gilead Sciences Company Details

13.7.2 Gilead Sciences Business Overview and Its Total Revenue

13.7.3 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Introduction

13.7.4 Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

13.7.5 Gilead Sciences Recent Development

13.8 Sanofi

13.8.1 Sanofi Company Details

13.8.2 Sanofi Business Overview and Its Total Revenue

13.8.3 Sanofi Pharmaceutics and Novel Drug Delivery Systems Introduction

13.8.4 Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

13.8.5 Sanofi Recent Development

13.9 Pfizer

13.9.1 Pfizer Company Details

13.9.2 Pfizer Business Overview and Its Total Revenue

13.9.3 Pfizer Pharmaceutics and Novel Drug Delivery Systems Introduction

13.9.4 Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

13.9.5 Pfizer Recent Development

13.10 Takeda

13.10.1 Takeda Company Details

13.10.2 Takeda Business Overview and Its Total Revenue

13.10.3 Takeda Pharmaceutics and Novel Drug Delivery Systems Introduction

13.10.4 Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

13.10.5 Takeda Recent Development

13.11 Bausch&Lomb

10.11.1 Bausch&Lomb Company Details

10.11.2 Bausch&Lomb Business Overview and Its Total Revenue

10.11.3 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Introduction

10.11.4 Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

10.11.5 Bausch&Lomb Recent Development

13.12 Samyang Biopharmaceuticals

10.12.1 Samyang Biopharmaceuticals Company Details

10.12.2 Samyang Biopharmaceuticals Business Overview and Its Total Revenue

10.12.3 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction

10.12.4 Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

10.12.5 Samyang Biopharmaceuticals Recent Development

13.13 Johnson & Johnson

10.13.1 Johnson & Johnson Company Details

10.13.2 Johnson & Johnson Business Overview and Its Total Revenue

10.13.3 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Introduction

10.13.4 Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

10.13.5 Johnson & Johnson Recent Development

13.14 TOLMAR

10.14.1 TOLMAR Company Details

10.14.2 TOLMAR Business Overview and Its Total Revenue

10.14.3 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Introduction

10.14.4 TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

10.14.5 TOLMAR Recent Development

13.15 Astellas

10.15.1 Astellas Company Details

10.15.2 Astellas Business Overview and Its Total Revenue

10.15.3 Astellas Pharmaceutics and Novel Drug Delivery Systems Introduction

10.15.4 Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

10.15.5 Astellas Recent Development

13.16 AMAG Pharmaceuticals

10.16.1 AMAG Pharmaceuticals Company Details

10.16.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue

10.16.3 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction

10.16.4 AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

10.16.5 AMAG Pharmaceuticals Recent Development

13.17 AbbVie

10.17.1 AbbVie Company Details

10.17.2 AbbVie Business Overview and Its Total Revenue

10.17.3 AbbVie Pharmaceutics and Novel Drug Delivery Systems Introduction

10.17.4 AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

10.17.5 AbbVie Recent Development

13.18 Dr Reddy

10.18.1 Dr Reddy Company Details

10.18.2 Dr Reddy Business Overview and Its Total Revenue

10.18.3 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Introduction

10.18.4 Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

10.18.5 Dr Reddy Recent Development

13.19 AstraZeneca

10.19.1 AstraZeneca Company Details

10.19.2 AstraZeneca Business Overview and Its Total Revenue

10.19.3 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Introduction

10.19.4 AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

10.19.5 AstraZeneca Recent Development

13.20 Aspen

10.20.1 Aspen Company Details

10.20.2 Aspen Business Overview and Its Total Revenue

10.20.3 Aspen Pharmaceutics and Novel Drug Delivery Systems Introduction

10.20.4 Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

10.20.5 Aspen Recent Development

13.21 Acrotech Biopharma

10.21.1 Acrotech Biopharma Company Details

10.21.2 Acrotech Biopharma Business Overview and Its Total Revenue

10.21.3 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Introduction

10.21.4 Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

10.21.5 Acrotech Biopharma Recent Development

13.22 TWi Pharmaceuticals

10.22.1 TWi Pharmaceuticals Company Details

10.22.2 TWi Pharmaceuticals Business Overview and Its Total Revenue

10.22.3 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction

10.22.4 TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

10.22.5 TWi Pharmaceuticals Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Disclaimer

15.3 Author Details

List of Tables

Table 1. Pharmaceutics and Novel Drug Delivery Systems Key Market Segments

Table 2. Key Players Covered: Ranking by Pharmaceutics and Novel Drug Delivery Systems Revenue

Table 3. Ranking of Global Top Pharmaceutics and Novel Drug Delivery Systems Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Liposomes

Table 6. Key Players of PEGylated Proteins & Polypeptides

Table 7. Key Players of Polymer Nanoparticle

Table 8. Key Players of Protein–drug Conjugates

Table 9. Key Players of Other

Table 10. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 11. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions (US$ Million): 2020 VS 2026

Table 12. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions (2015-2020) (US$ Million)

Table 13. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2015-2020)

Table 14. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 15. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2021-2026)

Table 16. Market Top Trends

Table 17. Key Drivers: Impact Analysis

Table 18. Key Challenges

Table 19. Pharmaceutics and Novel Drug Delivery Systems Market Growth Strategy

Table 20. Main Points Interviewed from Key Pharmaceutics and Novel Drug Delivery Systems Players

Table 21. Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Players (2015-2020) (Million US$)

Table 22. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Players (2015-2020)

Table 23. Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2019)

Table 24. Global Pharmaceutics and Novel Drug Delivery Systems by Players Market Concentration Ratio (CR5 and HHI)

Table 25. Key Players Headquarters and Area Served

Table 26. Key Players Pharmaceutics and Novel Drug Delivery Systems Product Solution and Service

Table 27. Date of Enter into Pharmaceutics and Novel Drug Delivery Systems Market

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)

Table 30. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Share by Type (2015-2020)

Table 31. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2021-2026)

Table 32. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Share by Application (2015-2020)

Table 33. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)

Table 34. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Share by Application (2021-2026)

Table 35. North America Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)

Table 36. North America Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)

Table 37. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)

Table 38. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)

Table 39. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)

Table 40. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)

Table 41. Europe Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)

Table 42. Europe Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)

Table 43. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)

Table 44. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)

Table 45. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)

Table 46. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)

Table 47. China Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)

Table 48. China Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)

Table 49. China Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)

Table 50. China Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)

Table 51. China Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)

Table 52. China Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)

Table 53. Japan Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)

Table 54. Japan Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)

Table 55. Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)

Table 56. Japan Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)

Table 57. Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)

Table 58. Japan Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)

Table 59. Southeast Asia Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)

Table 60. Southeast Asia Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)

Table 61. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)

Table 62. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)

Table 63. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)

Table 64. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)

Table 65. India Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)

Table 66. India Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)

Table 67. India Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)

Table 68. India Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)

Table 69. India Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)

Table 70. India Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)

Table 71. Central & South America Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)

Table 72. Central & South America Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)

Table 73. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)

Table 74. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)

Table 75. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)

Table 76. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)

Table 77. Amgen Company Details

Table 78. Amgen Business Overview

Table 79. Amgen Product

Table 80. Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 81. Amgen Recent Development

Table 82. Teva Company Details

Table 83. Teva Business Overview

Table 84. Teva Product

Table 85. Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 86. Teva Recent Development

Table 87. Roche Company Details

Table 88. Roche Business Overview

Table 89. Roche Product

Table 90. Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 91. Roche Recent Development

Table 92. UCB (Union Chimique Belge) Company Details

Table 93. UCB (Union Chimique Belge) Business Overview

Table 94. UCB (Union Chimique Belge) Product

Table 95. UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 96. UCB (Union Chimique Belge) Recent Development

Table 97. Celgene Company Details

Table 98. Celgene Business Overview

Table 99. Celgene Product

Table 100. Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 101. Celgene Recent Development

Table 102. Merck Company Details

Table 103. Merck Business Overview

Table 104. Merck Product

Table 105. Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 106. Merck Recent Development

Table 107. Gilead Sciences Company Details

Table 108. Gilead Sciences Business Overview

Table 109. Gilead Sciences Product

Table 110. Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 111. Gilead Sciences Recent Development

Table 112. Sanofi Business Overview

Table 113. Sanofi Product

Table 114. Sanofi Company Details

Table 115. Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 116. Sanofi Recent Development

Table 117. Pfizer Company Details

Table 118. Pfizer Business Overview

Table 119. Pfizer Product

Table 120. Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 121. Pfizer Recent Development

Table 122. Takeda Company Details

Table 123. Takeda Business Overview

Table 124. Takeda Product

Table 125. Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 126. Takeda Recent Development

Table 127. Bausch&Lomb Company Details

Table 128. Bausch&Lomb Business Overview

Table 129. Bausch&Lomb Product

Table 130. Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 131. Bausch&Lomb Recent Development

Table 132. Samyang Biopharmaceuticals Company Details

Table 133. Samyang Biopharmaceuticals Business Overview

Table 134. Samyang Biopharmaceuticals Product

Table 135. Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 136. Samyang Biopharmaceuticals Recent Development

Table 137. Johnson & Johnson Company Details

Table 138. Johnson & Johnson Business Overview

Table 139. Johnson & Johnson Product

Table 140. Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 141. Johnson & Johnson Recent Development

Table 142. TOLMAR Company Details

Table 143. TOLMAR Business Overview

Table 144. TOLMAR Product

Table 145. TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 146. TOLMAR Recent Development

Table 147. Astellas Company Details

Table 148. Astellas Business Overview

Table 149. Astellas Product

Table 150. Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 151. Astellas Recent Development

Table 152. AMAG Pharmaceuticals Company Details

Table 153. AMAG Pharmaceuticals Business Overview

Table 154. AMAG Pharmaceuticals Product

Table 155. AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 156. AMAG Pharmaceuticals Recent Development

Table 157. AbbVie Company Details

Table 158. AbbVie Business Overview

Table 159. AbbVie Product

Table 160. AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 161. AbbVie Recent Development

Table 162. Dr Reddy Company Details

Table 163. Dr Reddy Business Overview

Table 164. Dr Reddy Product

Table 165. Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 166. Dr Reddy Recent Development

Table 167. AstraZeneca Company Details

Table 168. AstraZeneca Business Overview

Table 169. AstraZeneca Product

Table 170. AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 171. AstraZeneca Recent Development

Table 172. Aspen Company Details

Table 173. Aspen Business Overview

Table 174. Aspen Product

Table 175. Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 176. Aspen Recent Development

Table 177. Acrotech Biopharma Company Details

Table 178. Acrotech Biopharma Business Overview

Table 179. Acrotech Biopharma Product

Table 180. Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 181. Acrotech Biopharma Recent Development

Table 182. TWi Pharmaceuticals Company Details

Table 183. TWi Pharmaceuticals Business Overview

Table 184. TWi Pharmaceuticals Product

Table 185. TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)

Table 186. TWi Pharmaceuticals Recent Development

Table 187. Research Programs/Design for This Report

Table 188. Key Data Information from Secondary Sources

Table 189. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Type: 2020 VS 2026

Figure 2. Liposomes Features

Figure 3. PEGylated Proteins & Polypeptides Features

Figure 4. Polymer Nanoparticle Features

Figure 5. Protein–drug Conjugates Features

Figure 6. Other Features

Figure 7. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Application: 2020 VS 2026

Figure 8. Hospitals & Clinic Case Studies

Figure 9. Cancer Treatment Centers Case Studies

Figure 10. Others Case Studies

Figure 11. Pharmaceutics and Novel Drug Delivery Systems Report Years Considered

Figure 12. Global Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth 2015-2026 (US$ Million)

Figure 13. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions: 2020 VS 2026

Figure 14. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2021-2026)

Figure 15. Porter's Five Forces Analysis

Figure 16. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Players in 2019

Figure 17. Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2019

Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2019

Figure 19. North America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. China Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. Japan Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. India Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)

Figure 25. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)

Figure 26. Amgen Total Revenue (US$ Million): 2019 Compared with 2018

Figure 27. Amgen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 28. Teva Total Revenue (US$ Million): 2019 Compared with 2018

Figure 29. Teva Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018

Figure 31. Roche Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 32. UCB (Union Chimique Belge) Total Revenue (US$ Million): 2019 Compared with 2018

Figure 33. UCB (Union Chimique Belge) Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 34. Celgene Total Revenue (US$ Million): 2019 Compared with 2018

Figure 35. Celgene Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 36. Merck Total Revenue (US$ Million): 2019 Compared with 2018

Figure 37. Merck Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 38. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018

Figure 39. Gilead Sciences Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 40. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 41. Sanofi Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 42. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 43. Pfizer Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 44. Takeda Total Revenue (US$ Million): 2019 Compared with 2018

Figure 45. Takeda Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 46. Bausch&Lomb Total Revenue (US$ Million): 2019 Compared with 2018

Figure 47. Bausch&Lomb Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 48. Samyang Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 49. Samyang Biopharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 50. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018

Figure 51. Johnson & Johnson Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 52. TOLMAR Total Revenue (US$ Million): 2019 Compared with 2018

Figure 53. TOLMAR Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 54. Astellas Total Revenue (US$ Million): 2019 Compared with 2018

Figure 55. Astellas Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 56. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 57. AMAG Pharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 58. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018

Figure 59. AbbVie Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 60. Dr Reddy Total Revenue (US$ Million): 2019 Compared with 2018

Figure 61. Dr Reddy Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 62. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018

Figure 63. AstraZeneca Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 64. Aspen Total Revenue (US$ Million): 2019 Compared with 2018

Figure 65. Aspen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed